Dis-chem revenue rose 9.4% to R17.9 billion in the 6 months to end August.
Loading player...
GUEST - GUEST - Rui Morais – Dis-Chem CEO
Pharmacy group Dis-Chem is growing revenue, profits are under pressure as it fights for market share in a tough economy. Group revenue rose 9.4% to R17.9 billion in the six months to end August, the group announced on Friday, or just over 10% when excluding the effect of Covid-19 vaccines in the prior period. But headline earnings fell about 17% to just under R500 million, with margins under pressure in personal care and beauty as the retailer picked up its promotional activity.
Pharmacy group Dis-Chem is growing revenue, profits are under pressure as it fights for market share in a tough economy. Group revenue rose 9.4% to R17.9 billion in the six months to end August, the group announced on Friday, or just over 10% when excluding the effect of Covid-19 vaccines in the prior period. But headline earnings fell about 17% to just under R500 million, with margins under pressure in personal care and beauty as the retailer picked up its promotional activity.
